SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is seeing a surge in bullish momentum as traders react to positive signals from the US government regarding crypto policy and reports of emergency liquidity measures in the bond market. The community is actively debating the sustainability of this rally, with many focusing on massive short liquidations and the potential for further upside as retail and institutional sentiment shifts.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares surged following positive Phase 3 results for its personalized mRNA skin cancer vaccine, fueling massive trading volume and sparking an intense short squeeze. The community remains deeply divided, with bulls pointing to the potential for a medical breakthrough while bears argue that the valuation has disconnected from the underlying data and imminent need for regulatory approval.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing significant attention as investors react to potential shifts in macro liquidity and anticipatory bullish sentiment surrounding upcoming regulatory developments. The community remains intensely focused on the asset's ability to maintain key price levels, with many traders discussing the prospect of a sustained recovery and the potential for a broader crypto cycle shift.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is seeing heavy community debate as Bitcoin rallies past $69,000, triggering a high-volume tug-of-war between bullish investors anticipating a massive short squeeze and vocal bears calling for further dilution. The stock remains a contentious focal point for traders tracking the CLARITY Act and broader crypto-sector rotation.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is surging following record quarterly earnings that beat analyst expectations, driven by increased trading volumes and the elimination of the Pattern Day Trader rule. The community is actively debating the potential for a short squeeze and price appreciation, with many traders looking for a breakout toward double-digit price targets.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. is trending as investors digest news that the SEC is actively working on a legal pathway for the Hyperliquid exchange to enter the U.S. market, sparking significant community excitement about its potential for long-term growth. Traders are closely monitoring the stock's high short interest and its relationship with the HYPE token, with many debating the impact of upcoming earnings and the potential for a gamma squeeze as the company navigates this expansion.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as the community scrutinizes the company's long-term licensing strategy and pivots toward a leaner operational model, while investors express frustration over the lack of concrete partnership announcements despite ongoing discussions with major pharmaceutical players. Discussions are heavily focused on the potential of the Matrix-M adjuvant technology and the hope that upcoming regulatory milestones with Sanofi will finally act as a definitive catalyst for the stock.

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

TRUMP CRYPTO is trending as retail investors and critics debate the project's legitimacy following reports of widespread losses among holders, while supporters argue for potential bullish reversals fueled by political developments and market speculation. Discussion is dominated by heated arguments between those labeling the asset a high-risk scam and enthusiasts holding out for a major short squeeze and political catalysts.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

VanEck Gold Miners ETF (GDX) is trending as investors react to a significant Treasury bond buyback announcement that has drawn comparisons to quantitative easing and intensified discussions regarding hidden liquidity stresses. The community is actively debating the gold thesis amidst concerns over the national debt, with many focusing on the potential for miners to serve as a hedge against fiscal instability and inflationary pressures.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is seeing increased bullish momentum as the community focuses on its aggressive share buybacks, significant Ethereum treasury accumulation, and anticipation surrounding upcoming legislative developments. Investors are actively debating the company's valuation relative to its crypto holdings, with many pinning hopes on a potential short squeeze while others remain cautious regarding management's capital allocation and dilution history.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ARWR  Bullish on ARWR&#39;s long term prospects.  ARO MAPT read out should be another proof that ARWR&#39;s platform can deliver across the blood brain barrier using a simple injection (rather than a spinal one).  This will, in it self, be a big development even if the readout involves healthy volunteers since cross the blood brain barrier this easily means ARWR an get other medicines across as well.   ARWR&#39;s public comments also suggest that (even better) they are anticipating a Tau reduction as well, which has implications for Alzheimer&#39;s treatment.   ARWR has developed an engine delivering meds across multiple tissue types at a good annual rate introducing new trials.  The bit picture here is that ARWR has a platform it can probably aim anywhere....and that, IMO, is a big deal that is more  important over the long run.

Bikerieder

sonnyG

Lougehrig

StockTwits Web

Arrowhead Pharmaceuticals Inc.

  Bullish on ARWR's long term prospects.  ARO MAPT read out should be another proof that ARWR's platform can deliver across the blood brain barrier using a simple injection (rather than a spinal one).  This will, in it self, be a big development even if the readout involves healthy volunteers since cross the blood brain barrier this easily means ARWR an get other medicines across as well.   ARWR's public comments also suggest that (even better) they are anticipating a Tau reduction as well, which has implications for Alzheimer's treatment.   ARWR has developed an engine delivering meds across multiple tissue types at a good annual rate introducing new trials.  The bit picture here is that ARWR has a platform it can probably aim anywhere....and that, IMO, is a big deal that is more  important over the long run.

J Hall

@JBH1949 If ARO-MAPT validates the subQ CNS platform I&#39;m really curious to find out what this obesity CNS Target X is:

 If ARO-MAPT validates the subQ CNS platform I'm really curious to find out what this obesity CNS Target X is:

Wolfman

@Wolfman5960  ARWR has, I believe, at least two other programs in the works where the focus is not disclosed, but I believe that one is ocular.  In any case, ARWR&#39;s platform looks like it will be a game changing delivery platform, rather than just a batch of new drugs that came out in isolation.....basically, I think ARWR is developing an engine that will keep producing new applications and that is the actual (yet undisclosed and hence unvalued) value in ARWR.  Of course, with biottechs, something could go wrong, but ARWR seems to have it&#39;s system working across tissue types rather than just being a company that comes up with a drug here and then another drug there, etc

  ARWR has, I believe, at least two other programs in the works where the focus is not disclosed, but I believe that one is ocular.  In any case, ARWR's platform looks like it will be a game changing delivery platform, rather than just a batch of new drugs that came out in isolation.....basically, I think ARWR is developing an engine that will keep producing new applications and that is the actual (yet undisclosed and hence unvalued) value in ARWR.  Of course, with biottechs, something could go wrong, but ARWR seems to have it's system working across tissue types rather than just being a company that comes up with a drug here and then another drug there, etc